Use of a VEGF antagonist to treat angiogenic eye disorders | Patent Number 09669069

US 09669069 B2
Application Number14972560
Publication NumberUS 20160101152 A1
Pendency1 year, 5 months, 22 days
Filled DateDec 17, 2015
Priority DateJan 13, 2011
Publication DateApr 14, 2016
Expiration DateJan 12, 2031
Inventor/ApplicantsGeorge D. Yancopoulos
ExaminesLOCKARD, JON MCCLELLAND
Art Unit1647
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.